RELAPSED/REFRACTORY AML
Clinical trials for RELAPSED/REFRACTORY AML explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY AML trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug tested in fight against aggressive blood cancers
Disease control OngoingThis early-phase study is testing a new antibody drug called bexmarilimab in combination with standard cancer therapies. It aims to find a safe dose and see if the combination helps adults with advanced forms of blood cancers like myelodysplastic syndrome (MDS) and acute myeloid …
Matched conditions: RELAPSED/REFRACTORY AML
Phase: PHASE1, PHASE2 • Sponsor: Faron Pharmaceuticals Ltd • Aim: Disease control
Last updated Apr 02, 2026 02:26 UTC
-
New hope for tough blood cancers: first patients test experimental drug
Disease control OngoingThis is the first time a new drug called BYON4413 is being tested in people. The study aims to find a safe dose and see if it helps patients with acute myeloid leukemia or myelodysplastic syndromes that have returned or not responded to standard treatments. It will first test inc…
Matched conditions: RELAPSED/REFRACTORY AML
Phase: PHASE1 • Sponsor: Byondis B.V. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope pill tested for tough blood cancers
Disease control OngoingThis early-stage study is testing a new oral medication called AUTX-703 for adults with advanced forms of blood cancer (AML or MDS) that have returned or stopped responding to other treatments. The main goal is to find a safe dose and see how the body handles the drug. Researcher…
Matched conditions: RELAPSED/REFRACTORY AML
Phase: PHASE1 • Sponsor: Auron Therapeutics, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC